Refined diagnostic criteria for the bipolar disorders: phase two of the AREDOC project.
DSM‐5
bipolar disorder
diagnosis
hypomania
mania
Journal
Acta psychiatrica Scandinavica
ISSN: 1600-0447
Titre abrégé: Acta Psychiatr Scand
Pays: United States
ID NLM: 0370364
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
accepted:
14
07
2020
entrez:
18
1
2021
pubmed:
19
1
2021
medline:
19
8
2021
Statut:
ppublish
Résumé
As limitations exist across DSM criteria sets for defining and differentiating the bipolar disorders generally and their component bipolar I (BP-1) and bipolar II (BP-II) sub-types, we sought to generate empirically based criteria. We formed an international Task Force (TF) comprising members with bipolar disorder expertise, and who recruited 74 patients with a TF-diagnosed bipolar I and 104 with a bipolar II condition (with patients responding to definitional queries and symptom questionnaires), while 33 unipolar depressed patients recruited by the first author also completed the symptom questionnaire. A factor analysis sought to determine granular hypo/manic constructs. The bipolar disorder subjects strongly affirmed a new general definition of a bipolar disorder (capturing both manic and hypomanic episodes). While DSM-5 requires impaired functioning, we established that a high percentage of individuals with a BP-I or a BP-II disorder reported improved functioning and therefore modified this criterion. Analyses identified syptoms with differential high rates in individuals with bipolar disorder and its sub-types (and thus not simply capturing happiness), while a factor analysis generated seven symptom constructs both linked with and differing from DSM-5 bipolar symptom criteria. This second-stage report details a new set of criteria for differentiating the bipolar disorders from unipolar depressive conditions, while arguing for BP-I and BP-II disorders being differentiated principally by the respective presence or absence of psychotic features. Future studies will evaluate whether further modifications are required and examine for differential treatment benefits for those with a BP-I versus a BP-II condition.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
193-202Informations de copyright
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Association;2020.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 11th ed. 2019. https://icd.who.int/
Parker G, Tavella G, Macqueen G et al. Revising Diagnostic and Statistical Manual of mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project. Aust N Z J Psychiatry 2019; 52: 1173–1182.
Jamison KR, Gerner RH, Hammen C et al. Clouds and silver linings: Positive experiences associated with primary affective disorders. Am. J. Psychiatry 1980;137:198–202.
Judd LL, Akiskal HS, Schettler PJ et al. Psychosocial disability in the course of bipolar I and II disorders: A prospective comparative longitudinal study. Arch. Gen. Psychiatry 2005;62:1322–1330.
Parker GB, Graham RK. Clinical characteristics associated with treatment‐resistant bipolar disorder. J. Nerv. Ment. Dis. 2017;205:188–191.
Goldberg JF, Harrow M. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis. J. Affect. Disord. 2005;89:79–89.